Navigation Links
HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
Date:10/1/2007

SAN DIEGO and SHANGHAI, China, Oct. 2 /PRNewswire/ -- HUYA Bioscience International (HUYA), a rapidly expanding biopharmaceutical company focused on the development of key disease-fighting drugs sourced from China, announced today that it has licensed a novel clinical stage anti-arrhythmic compound from the prestigious Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences.

The compound, HBI-3000 or sulcardine, exhibits a unique profile of myocardial ion channel regulation, compared to approved US and European anti- arrhythmic therapeutics. HBI-3000 has met significant Phase I safety milestones in three completed studies under a SIMM-sponsored Chinese IND. Gary T. Elliott, Pharm.D., Ph.D., Executive Vice President of Product Development at HUYA, commented that "the compound displays an ion channel selectivity profile that may contribute to effective treatment of both ventricular and atrial arrhythmias, while decreasing the risk of sudden death (Torsade de Pointes) associated with some anti-arrhythmics currently on the market."

Mireille Gingras, Ph.D., CEO of HUYA said, "There is a large unmet medical need for safer and more effective treatments for atrial and ventricular arrhythmia. We believe that HBI-3000 has the potential to fill this need, based on its unique properties and significant performance to date. By 2015, the global anti-arrhythmic market is expected to be $3.5 billion, and we feel we are on target to provide an innovative product."

Additional information is available at http://www.huyabio.com.

ABOUT HUYA

HUYA Bioscience International, LLC, with offices in San Diego and Shanghai, capitalizes on the explosive growth of the biotechnology and pharmaceutical industries in China. HUYA identifies and licenses promising Chinese pharmaceuticals for development and commercialization in Western markets. Using its management team and advisors, HUYA lowers the
'/>"/>

SOURCE HUYA Bioscience International, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Bioscience clusters: Too many or room for more?
5. Quintessence Biosciences names new president
6. Caden Biosciences may signal critical mass
7. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
8. WARF signs licensing pact with BD Biosciences
9. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
10. Bioscience beats beer
11. State awards QRG Biosciences development grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
(Date:6/18/2013)... AZ (PRWEB) June 18, 2013 ... services MeMD, Inc proudly announces the release of ... Health and Fitness ". , MeMD's goal was ... ever-changing landscape of Health 2.0, Health 3.0 and ... will likely transform medical care and the fitness ...
(Date:6/18/2013)... WA (PRWEB) June 18, 2013 Though ... -- 11,000, according to the U.S. Bureau of Labor Statistics ... increase of 24,000 per month. Most new health care jobs ... the hospital sector saw a loss of 6,000 jobs. Overall, ... outplacement consultancy firm Challenger, Gray & Christmas reported that a ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
Breaking Biology Technology:Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
... Timely Hearing before a NASDAQ Listing ... Qualifications Panel -, ... VRMLD) (the "Company"), a molecular diagnostics company,announced today that on March ... that, as a result of the Company,s,common stock closing at $1.00 ...
... Corp. (Nasdaq: MEMY ) today reported that ... explanatory,paragraph in their opinion on the Company,s financial ... Form 10-K for the year ended,December 31, 2007, ... a going,concern. The Company discusses this matter, including ...
... Organization,s National Networking ... And Expo ... (DA4S) (http://www.diversityallianceforscience.com ) has announced,that Merck & Co., Inc. will ... scheduled for May 19-20 at the Westin,Governors in Morristown, N.J. The ...
Cached Biology Technology:Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 2Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 3Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 4Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification 2Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Science's Inaugural Conference 2
(Date:6/17/2013)... of mining shale gas, is widespread across Pennsylvania, covering ... research in the Annals of the New York ... biodiversity including pollution from toxic chemicals, the building of ... "Shale gas has engendered a great deal of controversy, ... effects on biological diversity and resources have scarcely been ...
(Date:6/16/2013)... female sex workers in India reduce rates of syphilis, ... of Toronto study has found. , About ... the southern states of Andhra Pradesh, Karnataka, Maharashtra and ... from U of T,s Dalla Lana School of Public ... Research (CGHR), examined the impact of prevention among female ...
(Date:6/16/2013)... and move around the body called ,chase and run, ... at UCL. , Published in Nature Cell Biology ... when cancer cells interact with healthy cells in order to ... cells recruit healthy cells and use them to travel long ... could be controlled to design new therapies against cancer remains ...
Breaking Biology News(10 mins):HIV prevention among female sex workers in India reduces HIV and syphilis 2'Chase and run' cell movement mechanism explains process of metastasis 2
... scientists to track the habitat preferences and movements of ... managers protect overfished species such as red snapper and ... current online edition of the peer-reviewed Bulletin of ... exactly what areas to protect," says Matt Kendall, principle ...
... Results of the first study evaluating the use of human ... crops has found that the combination can be substituted for ... introducing any risk of disease for consumers. The study appears ... and Food Chemistry , a bi-weekly publication. In ...
... regulate the energy consumption of cells have a different structure ... healthy people, according to a new study from the Swedish ... The researchers believe that these ,epigenetic mutations, might have a ... Type II diabetes is characterised by a lower ...
Cached Biology News:NOAA scientists map fish habitat and movements at Gray's Reef Marine Sanctuary 2
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: